Orthopediatrics (KIDS) Research & Development (2016 - 2026)

Orthopediatrics has reported Research & Development for 11 years, with the latest figure at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 5.1% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (down 13.53% YoY), and the FY2025 full-year result was $9.1 million, down 17.51% from the prior year.
• Research & Development for Q1 2026 stood at $2.2 million, down from $2.3 million in the prior quarter.
• The five-year high for Research & Development was $3.0 million in Q1 2024, with the low at $1.7 million in Q2 2022.
• Average Research & Development over 5 years is $2.5 million, with a median of $2.4 million recorded in 2023.
• Year-over-year, Research & Development surged 69.78% in 2023 and fell 22.53% in 2025.
• Tracing KIDS's Research & Development over 5 years: stood at $2.5 million in 2022, then climbed by 18.2% to $2.9 million in 2023, then retreated by 0.21% to $2.9 million in 2024, then slipped by 22.53% to $2.3 million in 2025, then decreased by 1.24% to $2.2 million in 2026.
• The last three Research & Development figures came in at $2.2 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison